Labshake search
Citations for R&D Systems :
651 - 700 of 2564 citations for 2' 3' cGAMP STING based FRET Detection Kit 5 Plate since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... or TGF-ϕ31 (2 ng/ml; R&D System). For viral transduction ...
-
bioRxiv - Immunology 2024Quote: ... resuspended in BME type 2 (R&D Systems, 353300502), and cultured as previously described111 ...
-
bioRxiv - Microbiology 2024Quote: ... SARS-CoV-2 spike S2 (MAB10557, R&D systems), VSV-M[23H12] (Ab01404-2.0 ...
-
bioRxiv - Neuroscience 2021Quote: ... the plates were precoated with anti-TRKB antibody (1:1000, R&D Systems, #AF1494) in carbonate buffer (pH 9.8 ...
-
bioRxiv - Immunology 2022Quote: ... or plate-bound CD155-Fc chimera protein (CD155-IEGRMDP-Mouse IgG2a; R&D Systems). For plate coating with Abs or Fc ...
-
bioRxiv - Physiology 2023Quote: ... before plates were incubated with 3,3′,5,5′-tetramethylbenzidine (TMB) substrate solution (R&D Systems). Enzymatic reactions were quantified by measuring absorbance at 450 nm using a standard plate reader (Biotek Instrument).
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Developmental Biology 2019Quote: ... 5 ng/mL human recombinant FGF2 (R&D Systems #3139-FB) and 10μM of XAV939 (Abcam #ab120897) ...
-
bioRxiv - Microbiology 2021Quote: ... 5 ng/mL BMP-4 (314-BP-050, R&D Systems), 50 ng/mL VEGF (293-VE-500 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Genomics 2019Quote: ... and RUNX1 inhibitor (Ro 5-3335, R&D Systems, Shanghai, China) were added at 5 ng/mL and 10 ng/mL ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml recombinant human VEGF 165 protein (R&D Systems), 10 ng/ml human bFGF (Invitrogen) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL recombinant human VEGF 165 Protein (R&D Systems) and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Immunology 2020Quote: ... cells were pelleted and resuspended in 100 µL FACS buffer (2% FBS in DPBS) containing 0.2 µg goat-α-human Ace-2 (R&D Systems #AF933). After 30 min on ice ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Molecular Biology 2021Quote: ... in the presence of IL-3 (1 ng/mL, R&D Systems, Minneapolis, MN, USA) at 37°C and 5% CO2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Physiology 2020Quote: ... 3-day-old pups were intraperitoneally injected with sterile murine rIGF-1 (R&D systems) or sterile PBS daily at a dose of 200μg/kg until weaning age (21-days-old ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems), SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems). The medium was changed every 2 days ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Genomics 2024Quote: ... and 1 ng/mL recombinant human interleukin IL-3 (R&D systems, 203-IL/CF). Phase 2 includes phase 1 media without IL-3 and phase 3 includes phase 1 media without IL-3 and SCF with holo-transferrin increased to 1 mg/mL final concentration ...
-
bioRxiv - Immunology 2023Quote: Cytokines in the patient and control dermal fibroblast culture supernatants were measured using enzyme-linked immunosorbent assay (ELISA) for quantitative detection of IL-1β (R&D Systems Cat. No. DY201), tumour necrosis factor TNF-α (BioLegend® Cat ...
-
bioRxiv - Immunology 2022Quote: ... 2 ng/mL recombinant human TGF-β1 (R&D Systems), and 333 ng/mL anti-IgD dextran conjugates (Fina Biosolutions) ...
-
bioRxiv - Pathology 2019Quote: ... FGF-2 (20ng/mL, R&D Systems 233-FB-025) and EGF (20ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... 100 IU/ml recombinant human IL-2 (R&D Systems), and 50 μM beta-mercaptoethanol (Fisher) ...
-
bioRxiv - Bioengineering 2021Quote: ... Human/Mouse/Rat/Hamster ACE-2 (R&D systems, AF933), Human TRA-1-85/CD147 (R&D systems ...
-
bioRxiv - Microbiology 2019Quote: ... or FGF-2 protein levels using ELISA (R&D systems). The LDH release was calculated as described previously (83).
-
bioRxiv - Cancer Biology 2022Quote: ... and 50 IU/mL of IL-2 (R&D Systems)] for 7 days prior to use in cell killing assays ...
-
bioRxiv - Biochemistry 2022Quote: ... 2 µg of recombinant Mac-1 integrin (R&D systems) was incubated with reduced PDI or enzymatically inactive PDI at 10 µM for 30 min at 25°C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ul GDNF (R&D Systems #212-GD)) ...
-
bioRxiv - Genomics 2019Quote: ... and 2 ng/mL recombinant human GDNF (R&D Systems).
-
bioRxiv - Evolutionary Biology 2020Quote: ... 2 U/ml EPO (R&D Systems, 287-TC-500), 40 ng/ml IGF-1 (Miltenyi ...
-
bioRxiv - Immunology 2021Quote: ... or biotinylated goat-anti-mouse Dectin-2 (R&D Systems) followed by APC-conjugated streptavidin antibodies (Biolegend) ...